Uncategorized

Antibiotics Used in Critical Care Units

The patients in the ICU are at increased risk of acquiring infections due to severe illness, indwelling devices, and invasive procedures.

Antibiotics are widely used to treat severe infections like ventilator-associated pneumonia, sepsis, etc.

They are generally given through the intravenous route for prompt control.

The IV route offers 100% bioavailability.

The drug directly enters the bloodstream.

The commonly used antibiotics include:

Carbapenems:

These are broad-spectrum antibiotics, bactericidal in nature.

Common uses include:

  • Complicated intra-abdominal infections
  • Multidrug-resistant bacterial infections
  • Hospital-acquired pneumonia
  • Complicated urinary tract infection

Beta-lactam/beta-lactamase inhibitors –

Beta-lactam antibiotics are combined with beta-lactamase inhibitors.

Bacteria produce the beta-lactamase enzyme to break down the antibiotic structure.

Beta-lactamase inhibitors inhibit this enzyme.

The inhibitors help preserve the antibiotic structure and prevent its inactivation.

These are used to treat:

  • Respiratory infections
  • Urinary-tract infections
  • Intra-abdominal infections
  • Skin-soft tissue infection

Cephalosporins –

This is a class of beta-lactam antibiotics.

These are classified into 5 generations with different antibacterial activity.

These are widely used to treat –

  • Pneumonia
  • Skin /soft tissue infections
  • Meningitis
  • Bone or joint infections
  • Urinary tract infections

 Glycopeptides –

These may be used as an alternative in certain people with penicillin/cephalosporin allergies.

These may be used for specific Gram-positive bacterial infections, including:

  • MRSA- methicillin-resistant Staphylococcus aureus infection
  • Bone/joint infections
  • Pneumonia caused by susceptible Gram-positive bacteria
  • Sepsis caused by susceptible Gram-positive bacteria
  • Vancomycin is used in selected cases of C. difficile infection

Aminoglycosides –

These are potent antibiotics, bactericidal in nature.

They are effective against many aerobic and Gram-negative bacteria.

They may be used in selective cases:

  • Sepsis
  • UTI
  • Certain hospital-acquired infections
  • Bacterial Endocarditis

Which is the critical care medicine manufacturer in India?

Aprazer Healthcare is a pharmaceutical manufacturer and exporter.

We manufacture a wide range of antibiotic combinations.

As a critical care medicine manufacturer, we are a global exporter of antibiotics.

Our manufacturing units are GMP-certified and equipped with modern infrastructure.

Our flagship products for ICU care include:

  • Aptriax-S – Ceftriaxone and Sulbactam
  • Piperaxis-4.5 gm – Piperacillin and Tazobactam

Conclusion:

The drug choice and the dose are decided by the doctor after evaluating the patient’s condition, severity of infection, susceptibility, and conformity of the causative agent.

Antibiotic stewardship is important –

Antibiotic therapy must be reviewed based on culture and susceptibility results in order to minimize antimicrobial drug resistance.